N/A
Completed N=312
Interactive Study to Increase Glaucoma Adherence to Treatment
Source: ClinicalTrials.gov NCT00794170 ↗Enrolled (actual)
312
Serious AEs
0.0%
Results posted
Jun 2014
Primary outcomePrimary: Data on Prescription Drug Renewals, Appointment Compliance and Medication Taking (e.g. Physician Notes) — 150; 152 participants
Summary
Study participants who receive the I-SIGHT intervention will have higher rates of glaucoma treatment compliance (e.g., medication-taking and refill compliance, return for clinical follow-up) and more positive eye health outcomes at 12-month follow-up than participants who receive the control group intervention.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Data on Prescription Drug Renewals, Appointment Compliance and Medication Taking (e.g. Physician Notes) |
150; 152 | — |
Eligibility Criteria
Inclusion Criteria
- Receive treatment at the Atlanta VA Medical Center or Grady Eye clinic for their eye condition
- Be between the ages of 18-80
- Be Caucasian or African American
- Possess a telephone (home telephone or cellular phone)
- Speak and understand English
- Be diagnosed with open angle glaucoma, be glaucoma suspect, or be ocular hypertensive for at least one year
- Be prescribed daily doses of topical treatments for at least one year
- Be able to read or have someone who can help the participant with reading written materials that we give to the participant
Exclusion Criteria
- Having eye surgery within 3 months of baseline interview and enrollment
- Being legally blind (20/200 or worse)
Data sourced from ClinicalTrials.gov (NCT00794170). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.